PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 2001 March; 94(3): 119–123.
PMCID: PMC1297926

BCG immunotherapy for superficial bladder cancer.

Full Text

The Full Text of this article is available as a PDF (83K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hickey DP, Vivas CA, Jordan ML, Lopatin WB, Hrebinko R, O'Donovan R, Hakala TR. Highly sensitized patients with delayed graft function: a management protocol. J Urol. 1991 Jan;145(1):131–134. [PubMed]
  • Perlaky L, Valdez BC, Busch RK, Larson RG, Jhiang SM, Zhang WW, Brattain M, Busch H. Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct. Cancer Res. 1992 Jan 15;52(2):428–436. [PubMed]
  • Pagano F, Bassi P, Milani C, Meneghini A, Maruzzi D, Garbeglio A. A low dose bacillus Calmette-Guerin regimen in superficial bladder cancer therapy: is it effective? J Urol. 1991 Jul;146(1):32–35. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press